US20090004168A1 - Health Enhancement System - Google Patents
Health Enhancement System Download PDFInfo
- Publication number
- US20090004168A1 US20090004168A1 US11/861,132 US86113207A US2009004168A1 US 20090004168 A1 US20090004168 A1 US 20090004168A1 US 86113207 A US86113207 A US 86113207A US 2009004168 A1 US2009004168 A1 US 2009004168A1
- Authority
- US
- United States
- Prior art keywords
- portions
- amount
- daily
- daily portions
- day supply
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000036541 health Effects 0.000 title claims abstract description 34
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 17
- 239000011707 mineral Substances 0.000 claims abstract description 17
- 239000004615 ingredient Substances 0.000 claims description 60
- 239000002775 capsule Substances 0.000 claims description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 17
- FUSNOPLQVRUIIM-UHFFFAOYSA-N 4-amino-2-(4,4-dimethyl-2-oxoimidazolidin-1-yl)-n-[3-(trifluoromethyl)phenyl]pyrimidine-5-carboxamide Chemical compound O=C1NC(C)(C)CN1C(N=C1N)=NC=C1C(=O)NC1=CC=CC(C(F)(F)F)=C1 FUSNOPLQVRUIIM-UHFFFAOYSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- 244000269722 Thea sinensis Species 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 229910000377 hydrazine sulfate Inorganic materials 0.000 claims description 8
- 239000012493 hydrazine sulfate Substances 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 244000003240 Caesalpinia gilliesii Species 0.000 claims description 7
- 235000014161 Caesalpinia gilliesii Nutrition 0.000 claims description 7
- 235000011472 cat’s claw Nutrition 0.000 claims description 7
- 239000006014 omega-3 oil Substances 0.000 claims description 7
- 241000251730 Chondrichthyes Species 0.000 claims description 6
- 239000009749 Essiac Substances 0.000 claims description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 6
- 235000013734 beta-carotene Nutrition 0.000 claims description 6
- 239000011648 beta-carotene Substances 0.000 claims description 6
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 6
- 229960002747 betacarotene Drugs 0.000 claims description 6
- 210000000845 cartilage Anatomy 0.000 claims description 6
- 235000021388 linseed oil Nutrition 0.000 claims description 6
- 239000000944 linseed oil Substances 0.000 claims description 6
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 40
- 201000011510 cancer Diseases 0.000 abstract description 34
- 238000011282 treatment Methods 0.000 abstract description 22
- 235000010755 mineral Nutrition 0.000 abstract description 13
- 229940088594 vitamin Drugs 0.000 abstract description 13
- 229930003231 vitamin Natural products 0.000 abstract description 13
- 235000013343 vitamin Nutrition 0.000 abstract description 13
- 239000011782 vitamin Substances 0.000 abstract description 13
- 238000004806 packaging method and process Methods 0.000 abstract description 12
- 229930014626 natural product Natural products 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 235000008216 herbs Nutrition 0.000 abstract description 7
- 235000001014 amino acid Nutrition 0.000 abstract description 5
- 150000001413 amino acids Chemical class 0.000 abstract description 5
- 230000005907 cancer growth Effects 0.000 abstract description 4
- 239000000341 volatile oil Substances 0.000 abstract description 4
- 239000000047 product Substances 0.000 description 31
- 238000000034 method Methods 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 16
- 239000000203 mixture Substances 0.000 description 12
- 238000013480 data collection Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 235000013616 tea Nutrition 0.000 description 9
- 238000002512 chemotherapy Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 229940091250 magnesium supplement Drugs 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229930003316 Vitamin D Natural products 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000007124 immune defense Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 description 4
- 229940046008 vitamin d Drugs 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 240000005528 Arctium lappa Species 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 240000001745 Rheum palmatum Species 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 241001473768 Ulmus rubra Species 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 229940069978 calcium supplement Drugs 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229940087603 grape seed extract Drugs 0.000 description 2
- 235000002532 grape seed extract Nutrition 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 229940040461 lipase Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 229940023136 pantothenic acid 10 mg Drugs 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 229940106587 pine bark extract Drugs 0.000 description 2
- 235000020741 pine bark extract Nutrition 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 239000001195 (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid Substances 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 244000023431 Proboscidea parviflora Species 0.000 description 1
- 235000019096 Proboscidea parviflora Nutrition 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 240000007001 Rumex acetosella Species 0.000 description 1
- 235000015761 Rumex acetosella Nutrition 0.000 description 1
- 235000015316 Rumex sagittatus Nutrition 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 229940122803 Vinca alkaloid Drugs 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- -1 ascorbic acid ester Chemical class 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 238000011254 conventional chemotherapy Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 125000005481 linolenic acid group Chemical group 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- This invention provides a procedure and substances and generally, a health enhancement system which can be used to bolster or improve the body's resistance to certain life threatening conditions such as Cancer, AIDS, Diabetes, Hepatitis, Parkinson's Disease and others. It may be particularly useful when facing a threat or risk of some cancers in humans.
- the system may establish a health enhancement program through which is provided a group of natural products, vitamins and minerals, aminoacids, herbs and essential oils that may be helpful in aiding the body in fighting the growth of cancers and the progression of other diseases and in reducing the negative side effects of cancer and cancer treatment, and other diseases and their treatment(s). It may also assist in slowing, stopping, or reversing the growth of some cancers in the user.
- the body's ability to achieve a remission of a cancer is believed to be due to its being aided by a unique combination of selected ingredients and dosages.
- This system may: slow, stop, or reverse the growth of cancerous cells, and/or promotes and strengthen the human bodies own immune defense system against the cancerous cells. Additionally, this system may allow cancer victims to maintain a significant, higher health status, as defined by mobility, weight gain and energy level during treatment and post treatment.
- the ingredients may themselves be significant.
- the amount, timing and frequency in which the products are taken may have a significant impact on the treatment performance.
- the products may also be presented in a unit dose packaging system that may improve the patient's ability to accurately follow the use methodology prescribed.
- the packaging system may also be applied and used for other administrations as well.
- a set of medical tests may be required of the patient before and during the course of the treatment.
- the tests can be collected and analyzed by the administrator or a health professional to aid in obtaining information on the progress of the patient. There may also be further evidence of the efficacy of the products or the system in various cases.
- FIG. 1 illustrates a unit dose design according to one embodiment.
- FIGS. 2-4 each illustrate an embodiment of the packaging system aspect of the invention.
- the present invention provides both a formulation of ingredients and nutrients for a patient, a system of use, and a system of administration of such a treatment. It provides for the proper dosage and accurate ordering by a person in order to assure accuracy of such a potentially complex inter-relation of preferably natural substances.
- the invention may contain ingredients that have been selected based on their purported ability by themselves to slow or stop the growth of cancerous cells. It may also contain selected levels of vitamins, minerals, and other nutrients that have been determined to enhance the body's natural defense systems.
- the basic concepts of the present invention may be embodied in a variety of ways. It may involve, among other aspects, a set of ingredients, a series of formulations, a grouping of dosages, a packaging system, unit dose system, and even a data collection system in order to accomplish the intended results.
- the invention's differentiation from other treatments, in part, may be considered a result of the use of ingredients that when combined provide effects against cancer cells that may fall outside of, or in addition to the logical expectation of any single ingredient.
- Many natural products, herbs, vitamins and minerals have been tested as potential treatments against cancer.
- Recently, many researchers have tested single ingredients, or in some cases, combinations of two or three natural products against specific cancer types with mixed results. These mixed results may in part be due to the fact that the mechanisms of some various forms of cancer may not be well understood by current science or at least by the researchers.
- the mixed results may also be due to some degree by the fact that the researchers may have been primarily focused on finding a single product or ingredient, which is effective against a certain type of cancer. Interrelationships may have been difficult to understand.
- the invention may differ from the single ingredient/specific cancer approach. While the single ingredient/specific cancer approach may provide the most accurate information to the researcher on the mechanisms of cancer cell growth, it may do little for the patient who dies if the treatment is not effective against the type of cancer the patient has. In one embodiment, the invention may be considered as based upon the fact that a combination of ingredients working synergistically may prove to be more effective against cancer than any one ingredient by itself. This approach may result in better long-term success rates for cancer patients than any single ingredient can provide and tests seem to confirm this aspect.
- the present invention includes a variety of ingredients which may be ingested in a combined manner in different ways to achieve the intended result.
- At least one embodiment of the health enhancement system establishes a 60 day health enhancement program, but certainly programs of other lengths (including non-stop during the life of the program participant) should be understood as encompassed by this disclosure.
- the invention may be comprised of two subsets of products that when combined could have the ability to more effectively stop, slow, or even reverse a growth of cancer cells or to more appropriately enhance the body's own processes in such a situation.
- the first subset includes ingredients that have been previously reported to individually have specific, potentially direct effects on cancerous cells as follows:
- Shark Cartilage may inhibit the growth of blood vessels that feed cancerous tumors. This may cut off the nutrition to the tumor and therefore may not allow the tumor to continue to grow and mutate and to therefore die.
- Essiac Tea a four-herb tea developed by an oncology nurse in 1922, this formula may be excellent for maintaining and healing the liver which is responsible for detoxifying the blood which may be important in fighting cancer. This formulation may contain burdock root ( Arcticum lappa ), slippery elm ( Ulmus fulva ), turkey rhubarb ( Rheum palmatum ), and sheep sorel ( Rumex acetosella ). It may also itself serve to kill certain cancer cells. It may be prepared and used as set forth in Table 3. It may be important to note that the term essiac tea may refer to the herbal liquid (see Table 3) that may be used to make the prepared beverage upon dilution of the herbal liquid with warm water.
- the formula should be taken on an empty stomach to allow for better absorbability. Always take before eating. Wait 15 to 20 minutes before eating.
- the herbal formula can be taken 1 to 3 times per day.
- the herbal formula is non-toxic in proper doses and has a pleasant taste similar to black tea. These herbs do stimulate the body to throw off toxins and, therefore, it is important that you drink plenty of clean water and have regular bowel movements.
- the dosage is 3 times per day for as long as tests indicate the presence of cancer. Then 2 times per day for an additional year. For long term maintenance and gentle detoxification the dosage is 1 time per day.
- Flax Oil this is a source of linolenic and linoleic acids, which may be vital in providing nutrients to the non-cancer cells. These compounds contained in flax may also attack the mutating cells in a manner, which does not significantly affect healthy body cells and may not possess the destructive side effects of conventional chemotherapy.
- Omega 3 Oil this is an additional source of linoleic and linolenic acids from certain fish species. Hydrazine Sulfate: used to treat cachexia, and symptoms associated with chemotherapy, such as loss of hair, nausea, pain, weight loss, and general deterioration of vital organs, the body, and muscles. This may be considered a MAO inhibitor, and may allow the body to tolerate chemotherapy while allowing the organ systems to continue the processing of nutrition.
- Cat's Claw (Una de Gato) potentially a strong anti-oxidant although often used in central and south America for centuries as a general wellness product. It may have alkaloids (vinca alkaloids), which may have anti-tumor properties much like the chemotherapy drugs Vincristine and Vinblastine; only this nutritional product may be largely free of the side effects.
- a goal of this first subset of ingredients may be considered as providing multiple, alternative products that are selected to have some type of anti-cancer cell properties. Since the effects of each of the above ingredients on cell growth of the many different types of cancer may be considered as not totally understood by current science, in a general sense, the invention may be considered as providing multiple backups and synergies that may provide more effective control than any one or two of the products. As more data is collected (potentially as part of the invention's data collection system), other preferred embodiments may be derived. These embodiments may include more ingredients, or fewer, as the results dictate.
- the second subset of ingredients can be generally described as natural products, vitamins and minerals that are selected for their positive effects on the body's ability to build and maintain a healthy immune defense system.
- This subset of ingredients may include the following:
- Vitamin C (ascorbic acid ester) a necessary building block to provide energy for the Krebs cycle as well as an excellent anti-oxidant.
- Vitamin A (beta-carotene) a strong antioxidant that deals directly with and destroys free radicals produced from use of radiation and chemotherapy.
- Vitamin E (d-alpha-tocopherol) another strong antioxidant as well as a facilitator of fat-soluble vitamins. Also responsible for regulation of blood flow with regard to prevention of blood clots.
- Products sold under the trademark Heritage PlatinumTM: (oligomeric proanthocyanidins) or the like (such as provided by Heritage HealthTM Products) may provide strengthened immune function, stimulates T-4 killer cell production as well as white blood cell production, which may be critical to attacking mutated cancer cells. This may serve as an overall nutritional supplement for the immune system.
- Products sold under the trademark Heritage GoldTM or the like (such as provided by Heritage HealthTM Products): a digestive enzyme product, which is critical in the breakdown of food. Often cancer patients are intolerant to retention of food; this may serve to break down the food and ensure absorption via the small intestine. This product may also allow absorption of all of the nutritional supplements listed herein as well.
- a goal of this second subset of ingredients may be to provide the body with important nutrients and vitamins that may allow the body's natural immune defense system to complement the first subset of ingredients. This may also provide far more effective control of the cancer cells, and may maintain better health in the patient. Because the effects of each of the above ingredients on the body's natural immune defense system may also be considered as not totally understood by current science from some perspectives, the invention may again provide multiple backups and synergies that may provide more effective control than any one product. Again, as data is collected (perhaps as part of the invention's data collection system), other preferred embodiments may be derived. These embodiments may include more ingredients, or fewer, or some additional ones, as results dictate.
- the dosage and/or timing of the ingredients may be considered important.
- One such system of dosages and timing is shown in Tables 1 and 2.
- these dosages and/or timings of the listed ingredients are elements of a health enhancement system establishing a health enhancement program that, in Tables 1 and 2, is a preferred embodiment as currently understood.
- Other dosages and timings may prove to be appropriate and may produce satisfactory results and to the extent the ingredients are disclosed herein, all permutations and combinations—even of each elements' sub-elements—should be understood as encompassed by this disclosure.
- Flax Oil - 2 capsules 1,000 mg each) each morning and evening.
- Heritage Omega-3 Oil 1 2 capsules (1,000 mg each) each morning and evening.
- Shark Cartilage - 5 capsules 250 mg each) each morning and evening.
- Heritage Dino Bites - (montmorillinite minerals) 1 tablet (300 mg) each morning and evening.
- Vitamin C - 2 tablets 500 mg each) each morning and evening.
- Heritage Complete - 2 tablets each morning and evening.
- Each tablet consists of multivitamins and minerals:: Vitamin A 1,666 IU Vitamin C 100 mg Vitamin D 66 IU Vitamin E 33 IU Vitamin K 13 mcg Thiamin 2.5 mg Riboflavin 2.8 mg Niacin 17 mg Vitamin B6 3.3 mg Folic Acid 67 mcg Vitamin B12 10 mcg Biotin 50 mcg Pantothenic Acid 10 mg Calcium proteinate 17 mg Iodine 25 mcg Magnesium 17 mg Zinc 2.5 mg Selenium 12 mcg Copper proteinate 0.33 mg Manganese 1.7 mg Chromium 34 mcg Molybdenum 17 mcg Potassium 17 mg Garlic Cloves 83 mg Choline 34 mg Inositol 17 mg PABA 17 mg Boron 0.5 mg Octosanol 0.5 mg Silicon 0.17 mg Vanadium 17 mcg Blend: Chlorella , Korean Ginseng, Lemon bioflavenoids, Papain, Rose Hips, Rutin, Coenzyme Q 10.
- Each tablet contains: Vitamin D 10 IU Hydroxyadpatite and citrate 250 mg Magnesium (as citrate) 100 mg 9.
- Heritage Platinum - 2 capsules each morning and evening.
- Each capsule contains: Pine Bark Extract 10 mg Grape Seed Extract 40 mg Blend of citrus bioflavenoids, Rutin, Quercetin 10.
- Heritage Cat's Claw 1 1 capsule 600 mg each morning and evening 11.
- Heritage Gold - 1 capsule each morning and evening.
- Each capsule contains Pancreatin, Lactase, Lipase, Amylase, Catalase, Chrymotrypsin, Trypsin, Cellulase, Zinc Gluconate.
- Vitamin E - 1 softgel 400 IU) each morning and evening.
- Flax Oil - 2 capsules 1,000 mg each) each morning and evening.
- Heritage Omega-3 Oil - 2 capsules 1,000 mg each) each morning and evening.
- Shark Cartilage - 10 capsules 250 mg each) each morning and evening.
- Heritage Dino Bites - (montmorillinite minerals) 1 tablet (300 mg) each morning and evening.
- Vitamin C - 2 tablets 500 mg each) each morning and evening.
- Each tablet consists of multivitamins and minerals:: Vitamin A 1,666 IU Vitamin C 100 mg Vitamin D 66 IU Vitamin E 33 IU Vitamin K 13 mcg Thiamin 2.5 mg Riboflavin 2.8 mg Niacin 17 mg Vitamin B6 3.3 mg Folic Acid 67 mcg Vitamin B12 10 mcg Biotin 50 mcg Pantothenic Acid 10 mg Calcium proteinate 17 mg Iodine 25 mcg Magnesium 17 mg Zinc 2.5 mg Selenium 12 mcg Copper proteinate 0.33 mg Manganese 1.7 mg Chromium 34 mcg Molybdenum 17 mcg Potassium 17 mg Garlic Cloves 83 mg Choline 34 mg Inositol 17 mg PABA 17 mg Boron 0.5 mg Octosanol 0.5 mg Silicon 0.17 mg Vanadium 17 mcg Blend: Chlorella , Korean Ginseng, Lemon bioflavenoids, Papain, Rose Hips, Rutin, Coenzyme Q 10.
- the user may also be encouraged to modify their diet in two main ways. First, to greatly reduce fat content to less than 25% of total daily caloric intake, especially of saturated fats. Second, to add daily portions of cruciferous vegetables at every meal possible.
- the multiple synergies and backups may provide more effective control than any one treatment or therapy.
- the invention may be presented to a user in a unit dose design.
- the appropriate dose of each ingredient may even be packaged for sequential use, such as once each morning and evening by the user.
- This design may increase the accuracy and timing of the dosing by the patient, and may increase the efficacy.
- one goal of this feature of the invention may be to make a complex administration system easier for the patient to take the proper dosage at the correct times.
- the proper dosage of each of the ingredients may be included as part of a package of ingredients (5) that comprises daily portions of a multi-day supply (such as a one week or seven day supply, e.g.) usable in a health enhancement program for use by the patient at the preferred times, e.g., once each morning and evening.
- a multi-day supply such as a one week or seven day supply, e.g.
- other dosages and timings may be appropriate to give the intended result.
- combinations using morning and evening administrations as well as three times per day, four times per day, and even once per day (as but a few examples) should be understood as encompassed by this disclosure as each may be appropriate in a given context.
- the ingredients are relationally coordinated in that the type and/or dosage and/or timing is selected to cause a health enhancing effect. Based on the information gathered through the use of the data collection system, dosages and timings of each ingredient may even be altered, increased or decreased to maximize the effectiveness. A rapid feedback process may even be implemented to optimize effectiveness for each user.
- a data collection system may be implemented.
- certain personal, usage, and/or medical records of the patient/customer may be collected.
- One goal of this system may be to insure that information is gathered which may be necessary to allow the effectiveness of the invention to be demonstrated, and which may be useful to consider adjustments made to the ingredients, timing, dosages and packaging system for maximum effectiveness, and which may be useful for marketing purposes.
- this system may serve to encourage the customer/patient to be under the care of a medical professional which may not only assure optimal care, but it may also enhance the perceptions by the patient and thereby enhance the system's effectiveness.
- the data collection system may be designed to require that each patient/customer of a kit produce certain medical records at the time of purchase. These records may include diagnosis, prognosis, list of current medicines, treatment and medical history and other appropriate tests such as blood tests etc. Periodically, the patient/customer may also be required to update these medical records, such as on a monthly, weekly, bi-weekly, or even bimonthly basis, but at least at the time of each subsequent sale, in order to track the progress of their disease and perhaps even determine the propriety of any additional purchases.
- the present invention includes a variety of aspects, which may be combined in different ways.
- the following descriptions are provided to list elements and describe some of the embodiments of the present invention. These elements are listed with initial embodiments, however it should be understood that they may be combined in any manner and in any number to create additional embodiments.
- the variously described examples and preferred embodiments should not be construed to limit the present invention to only the explicitly described systems, techniques, and applications. Further, this description should further be understood to support and encompass descriptions and claim of all the various embodiments, systems, techniques, methods, devices, and applications with any number of the disclosed elements, with each element alone, and also with any and all various permutations and combinations of all elements in this or any subsequent application.
- the basic concepts of the present invention may be embodied in a variety of ways.
- the invention may be considered as involving a combination of ingredients, formulations of the ingredients, timing and dosages of ingredients, a unit dose system, a health enhancement system that establishes a health enhancement program, a packaging system and the like as well as all combinations and permutations of these to improve the efficacy of treatments. It may also include a data collection system to accomplish the desired result of slowing or stopping the growth of cancer cells or the disease in humans and other purposes. While some ingredients, formulations, dosing, methods of packaging and a system of data collection are disclosed, it should be understood that these not only accomplish certain results but also can be varied in a number of ways. Importantly, as to all of the foregoing each and all of these facets should be understood to be encompassed by this disclosure.
- each of the various elements of the invention and claim may also be achieved in a variety of manners.
- This disclosure should be understood to encompass each such variation, be it a variation of an embodiment of any apparatus embodiment, a method or process embodiment, or even merely a variation of any element of these.
- the words for each element may be expressed by equivalent apparatus terms or method terms—even if only the function or result is the same.
- Such equivalent, broader, or even more generic terms should be considered to be encompassed in the description of each element or action. Such terms can be substituted where desired to make explicit the implicitly broad coverage to which this invention is entitled.
- each of the health enhancement systems as herein disclosed and described ii) the related methods disclosed and described, iii) similar, equivalent, and even implicit variations of each of these systems and methods, iv) those alternative designs which accomplish each of the functions shown as are disclosed and described, v) those alternative designs and methods which accomplish each of the functions shown as are implicit to accomplish that which is disclosed and described, vi) each feature, component, and step shown as separate and independent inventions, vii) the applications enhanced by the various systems or components disclosed, viii) the resulting products produced by such systems or components, ix) each system, method, and element shown or described as now applied to any specific field or devices mentioned, x) methods and apparatuses substantially as described hereinbefore and with reference to any of the accompanying examples, xi) the various combinations and permutations of each of the elements disclosed, and xii) each potentially dependent claim or concept as a dependency on each and every one
- any claim set forth at any time are hereby incorporated by reference as part of this description of the invention, and the applicant expressly reserves the right to use all of or a portion of such incorporated content of such claim as additional description to support any of or all of the claim or any element or component thereof, and the applicant further expressly reserves the right to move any portion of or all of the incorporated content of such claim or any element or component thereof from the description into the claim or vice-versa as necessary to define the matter for which protection is sought by this application or by any subsequent continuation, division, or continuation-in-part application thereof, or to obtain any benefit of, reduction in fees pursuant to, or to comply with the patent laws, rules, or regulations of any country or treaty, and such content incorporated by reference shall survive during the entire pendency of this application including any subsequent continuation, division, or continuation-in-part application thereof or any reissue or extension thereon.
Abstract
A health enhancement system establishing a health enhancement program through which may be provided a group of natural products, vitamins and minerals, amino acids, herbs and essential oils that may be helpful in aiding the body in fighting the growth of cancers and the progression of other diseases and in reducing the negative side effects of cancer and cancer treatment, and other diseases and their treatment. At least one embodiment of the invention involves a packaging system of the group of natural products, vitamins and minerals, amino acids, herbs and essential oils that the health enhancement system may comprise.
Description
- This application is a divisional application of U.S. application Ser. No. 10/612,321 filed 1 Jul. 2003, now U.S. Pat. No. 7,273,607, which claims the benefit and priority of U.S. Provisional Application 60/393,717, filed 1 Jul. 2002, entitled “System for Improving Results of Treatments and Also for Enhancing an Ability to Resist Certain Types of Disease”, each said applications hereby incorporated by reference herein.
- This invention provides a procedure and substances and generally, a health enhancement system which can be used to bolster or improve the body's resistance to certain life threatening conditions such as Cancer, AIDS, Diabetes, Hepatitis, Parkinson's Disease and others. It may be particularly useful when facing a threat or risk of some cancers in humans. The system may establish a health enhancement program through which is provided a group of natural products, vitamins and minerals, aminoacids, herbs and essential oils that may be helpful in aiding the body in fighting the growth of cancers and the progression of other diseases and in reducing the negative side effects of cancer and cancer treatment, and other diseases and their treatment(s). It may also assist in slowing, stopping, or reversing the growth of some cancers in the user. According to one embodiment, the body's ability to achieve a remission of a cancer is believed to be due to its being aided by a unique combination of selected ingredients and dosages. This system may: slow, stop, or reverse the growth of cancerous cells, and/or promotes and strengthen the human bodies own immune defense system against the cancerous cells. Additionally, this system may allow cancer victims to maintain a significant, higher health status, as defined by mobility, weight gain and energy level during treatment and post treatment. In one embodiment the ingredients may themselves be significant. In another embodiment, the amount, timing and frequency in which the products are taken may have a significant impact on the treatment performance. The products may also be presented in a unit dose packaging system that may improve the patient's ability to accurately follow the use methodology prescribed. As should be appreciated, the packaging system may also be applied and used for other administrations as well. In order to track effectiveness and/or assure system processes, a set of medical tests may be required of the patient before and during the course of the treatment. The tests can be collected and analyzed by the administrator or a health professional to aid in obtaining information on the progress of the patient. There may also be further evidence of the efficacy of the products or the system in various cases.
- There have been numerous research reports and claim published on the ability of natural products, vitamins and minerals to provide either enhancements or even effective, alternative means for conventional treatments (surgery, chemotherapy and radiation) of some human cancers. Most of this research has focused on the use of one or a limited number of natural products against a particular type of cancer. Often research has been inconclusive with both positive and negative results reported. The present invention provides a new approach to both the products used, the systems followed, and the reporting requirements of a treatment system. It may be applicable in a wide range of treatments; however, it is of particular applicability for a multi-faceted treatment such as proposed to bolster a battle against certain forms of cancer. In one embodiment, the invention may also be used in combination or conjunction with conventional treatments such as surgery, chemotherapy and radiation therapy. This combination may again provide multiple backups and synergies that may provide more effective control than any one treatment or product or therapy. Again, as data is collected (perhaps as part of the inventions data collection system) other preferred embodiments may also be derived.
-
FIG. 1 illustrates a unit dose design according to one embodiment. -
FIGS. 2-4 each illustrate an embodiment of the packaging system aspect of the invention. - It is a goal of this invention to provide the cancer patient with a complement of natural products, vitamins, minerals, amino acids, herbs and essential oils and other ingredients that may directly attack the cancerous cells, which may strengthen and improve the body's own defense immune system against cancer, or which may otherwise aid a person in a battle against cancer and other diseases. The present invention provides both a formulation of ingredients and nutrients for a patient, a system of use, and a system of administration of such a treatment. It provides for the proper dosage and accurate ordering by a person in order to assure accuracy of such a potentially complex inter-relation of preferably natural substances. In one embodiment, the invention may contain ingredients that have been selected based on their purported ability by themselves to slow or stop the growth of cancerous cells. It may also contain selected levels of vitamins, minerals, and other nutrients that have been determined to enhance the body's natural defense systems.
- As can be easily understood, the basic concepts of the present invention may be embodied in a variety of ways. It may involve, among other aspects, a set of ingredients, a series of formulations, a grouping of dosages, a packaging system, unit dose system, and even a data collection system in order to accomplish the intended results.
- In one embodiment, the invention's differentiation from other treatments, in part, may be considered a result of the use of ingredients that when combined provide effects against cancer cells that may fall outside of, or in addition to the logical expectation of any single ingredient. Many natural products, herbs, vitamins and minerals have been tested as potential treatments against cancer. Recently, many researchers have tested single ingredients, or in some cases, combinations of two or three natural products against specific cancer types with mixed results. These mixed results may in part be due to the fact that the mechanisms of some various forms of cancer may not be well understood by current science or at least by the researchers. The mixed results may also be due to some degree by the fact that the researchers may have been primarily focused on finding a single product or ingredient, which is effective against a certain type of cancer. Interrelationships may have been difficult to understand.
- In one embodiment, the invention may differ from the single ingredient/specific cancer approach. While the single ingredient/specific cancer approach may provide the most accurate information to the researcher on the mechanisms of cancer cell growth, it may do little for the patient who dies if the treatment is not effective against the type of cancer the patient has. In one embodiment, the invention may be considered as based upon the fact that a combination of ingredients working synergistically may prove to be more effective against cancer than any one ingredient by itself. This approach may result in better long-term success rates for cancer patients than any single ingredient can provide and tests seem to confirm this aspect.
- The present invention includes a variety of ingredients which may be ingested in a combined manner in different ways to achieve the intended result. At least one embodiment of the health enhancement system establishes a 60 day health enhancement program, but certainly programs of other lengths (including non-stop during the life of the program participant) should be understood as encompassed by this disclosure.
- Each of these ingredients is first discussed separately with a preferred combination also mentioned. However all the various permutations and combinations of the individual ingredients should be understood as encompassed by this disclosure.
- The invention may be comprised of two subsets of products that when combined could have the ability to more effectively stop, slow, or even reverse a growth of cancer cells or to more appropriately enhance the body's own processes in such a situation. The first subset includes ingredients that have been previously reported to individually have specific, potentially direct effects on cancerous cells as follows:
- Shark Cartilage: may inhibit the growth of blood vessels that feed cancerous tumors. This may cut off the nutrition to the tumor and therefore may not allow the tumor to continue to grow and mutate and to therefore die.
Essiac Tea: a four-herb tea developed by an oncology nurse in 1922, this formula may be excellent for maintaining and healing the liver which is responsible for detoxifying the blood which may be important in fighting cancer. This formulation may contain burdock root (Arcticum lappa), slippery elm (Ulmus fulva), turkey rhubarb (Rheum palmatum), and sheep sorel (Rumex acetosella). It may also itself serve to kill certain cancer cells. It may be prepared and used as set forth in Table 3. It may be important to note that the term essiac tea may refer to the herbal liquid (see Table 3) that may be used to make the prepared beverage upon dilution of the herbal liquid with warm water. - The following lists a preparation procedure and some use options for the essiac tea feature of the invention.
-
-
- Preparation of the 4-Herb Formula
- Supplies Needed:
- Stainless steel or enamel canning pot (size: 2 gallons or 8 liters) with lid. (Do not use aluminum.)
- Another large pot to pour hot liquid into while you strain it. This can be Pyrex or stainless steel.
- Stainless steel mesh strainer and spoon and ladle (a large soup serving spoon)16 ounce (⅛ liter) or 32 ounce (¼ liter) amber glass bottles in which to store your finished product (they should be amber or a dark color, as the formula is light sensitive and will not stay as potent in clear glass bottles)
- Preparation of the 4-Herb Formula
- To make the one gallon recipe, use the four herb-package (approximately ½ cup). Bring one gallon of water to a boil. Stir in herbs, replace lid and boil for 10 minutes. Turn off stove, scrape down sides, mix well and allow pot to sit and remain closed for 12 hours.
- (This is the Steeping and Extraction Process.)
- After 12 or more hours, reheat to almost boiling (about 10 minutes). Let cool for 5 minutes and begin straining process. Strain as many times as you like. A little herb left in the liquid will not hurt it in any way. It is also satisfactory to allow the solids, etc. to settle to the bottom and then skim off the liquid with a soup ladle. Reheat your liquid once again (2 to 3 minutes only). This will kill any bacteria that may have landed in your liquid and help keep it from spoiling.
- Using a funnel or a glass measuring cup, put your hot liquid into preheated bottles. You can heat the bottles in the oven at 200 degrees for 5 or 10 minutes. Do not put bottle caps in oven!
- Cap, let cool and then put in the refrigerator. This will be good for one month. Label the bottles the day you make the tea and also the day it expires.
-
Mix 2 ounces of herbal liquid with two ounces of warm water. Never heat this formula or the hot water in a microwave! - The formula should be taken on an empty stomach to allow for better absorbability. Always take before eating. Wait 15 to 20 minutes before eating.
- This formula can be taken 1 to 3 times per day. The herbal formula is non-toxic in proper doses and has a pleasant taste similar to black tea. These herbs do stimulate the body to throw off toxins and, therefore, it is important that you drink plenty of clean water and have regular bowel movements.
- For cancer and serious ailments the dosage is 3 times per day for as long as tests indicate the presence of cancer. Then 2 times per day for an additional year. For long term maintenance and gentle detoxification the dosage is 1 time per day.
- Flax Oil: this is a source of linolenic and linoleic acids, which may be vital in providing nutrients to the non-cancer cells. These compounds contained in flax may also attack the mutating cells in a manner, which does not significantly affect healthy body cells and may not possess the destructive side effects of conventional chemotherapy.
Omega 3 Oil: this is an additional source of linoleic and linolenic acids from certain fish species.
Hydrazine Sulfate: used to treat cachexia, and symptoms associated with chemotherapy, such as loss of hair, nausea, pain, weight loss, and general deterioration of vital organs, the body, and muscles. This may be considered a MAO inhibitor, and may allow the body to tolerate chemotherapy while allowing the organ systems to continue the processing of nutrition.
Cat's Claw: (Una de Gato) potentially a strong anti-oxidant although often used in central and south America for centuries as a general wellness product. It may have alkaloids (vinca alkaloids), which may have anti-tumor properties much like the chemotherapy drugs Vincristine and Vinblastine; only this nutritional product may be largely free of the side effects. - In one embodiment, a goal of this first subset of ingredients may be considered as providing multiple, alternative products that are selected to have some type of anti-cancer cell properties. Since the effects of each of the above ingredients on cell growth of the many different types of cancer may be considered as not totally understood by current science, in a general sense, the invention may be considered as providing multiple backups and synergies that may provide more effective control than any one or two of the products. As more data is collected (potentially as part of the invention's data collection system), other preferred embodiments may be derived. These embodiments may include more ingredients, or fewer, as the results dictate.
- The second subset of ingredients can be generally described as natural products, vitamins and minerals that are selected for their positive effects on the body's ability to build and maintain a healthy immune defense system. This subset of ingredients may include the following:
- Products sold under the trademark Heritage Complete™ or the like (such as provided by Heritage Health™ Products): A particularly good multiple vitamin and amino acid and mineral product. This may be selected to provide the body the basic building blocks of nutritional components to sustain health during the cancer fight and thereafter their ingredients (To the extent composite products such as this are referenced, all each incorporated by reference herein.), as publicly available.
- Products sold under the trademark Dino Bites™ or the like (such as provided by Heritage Health™ Products): a montmorillonite mineral supplement used in concert with the above complete multiple vitamin product to ensure absorption of the vitamins and to provide more than sixty trace minerals.
- Vitamin C: (ascorbic acid ester) a necessary building block to provide energy for the Krebs cycle as well as an excellent anti-oxidant.
- Vitamin A: (beta-carotene) a strong antioxidant that deals directly with and destroys free radicals produced from use of radiation and chemotherapy.
- Vitamin E: (d-alpha-tocopherol) another strong antioxidant as well as a facilitator of fat-soluble vitamins. Also responsible for regulation of blood flow with regard to prevention of blood clots.
- Products sold under the trademark Heritage Osteoguard™ or the like (such as provided by Heritage Health™ Products): a hydroxyadpatite calcium and magnesium supplement that may ensure the patient has bone strength. Chemotherapy, without a calcium supplement, can remove the required calcium from the bones of the patient, ultimately causing weakness and a general sense of malaise.
- Products sold under the trademark Heritage Platinum™: (oligomeric proanthocyanidins) or the like (such as provided by Heritage Health™ Products) may provide strengthened immune function, stimulates T-4 killer cell production as well as white blood cell production, which may be critical to attacking mutated cancer cells. This may serve as an overall nutritional supplement for the immune system.
- Products sold under the trademark Heritage Gold™ or the like (such as provided by Heritage Health™ Products): a digestive enzyme product, which is critical in the breakdown of food. Often cancer patients are intolerant to retention of food; this may serve to break down the food and ensure absorption via the small intestine. This product may also allow absorption of all of the nutritional supplements listed herein as well.
- In one embodiment, a goal of this second subset of ingredients may be to provide the body with important nutrients and vitamins that may allow the body's natural immune defense system to complement the first subset of ingredients. This may also provide far more effective control of the cancer cells, and may maintain better health in the patient. Because the effects of each of the above ingredients on the body's natural immune defense system may also be considered as not totally understood by current science from some perspectives, the invention may again provide multiple backups and synergies that may provide more effective control than any one product. Again, as data is collected (perhaps as part of the invention's data collection system), other preferred embodiments may be derived. These embodiments may include more ingredients, or fewer, or some additional ones, as results dictate.
- In one preferred embodiment of the health enhancement system, the dosage and/or timing of the ingredients may be considered important. One such system of dosages and timing is shown in Tables 1 and 2. Importantly, it should be understood that these dosages and/or timings of the listed ingredients are elements of a health enhancement system establishing a health enhancement program that, in Tables 1 and 2, is a preferred embodiment as currently understood. Other dosages and timings may prove to be appropriate and may produce satisfactory results and to the extent the ingredients are disclosed herein, all permutations and combinations—even of each elements' sub-elements—should be understood as encompassed by this disclosure. Specifically, elimination of one or more of the ingredients from the system presented in Tables 1 and 2, or alteration of the dosage and/or timing of the ingredients presented in Tables 1 and 2 is to be understood as encompassed by this disclosure. As data is collected (perhaps as part of the invention's data collection system), other preferred embodiments may be derived. These embodiments may include higher or lower dosages of each of the ingredients, separately or in total. It may be important to understand that a daily portion of any ingredient may be in two or more smaller portions (e.g., one of which is for ingestion in the morning and the other, in the evening).
-
TABLE 1 Products and Dosage 1. Flax Oil - 2 capsules (1,000 mg each) each morning and evening. 2. Heritage Omega-3 Oil 1 2 capsules (1,000 mg each) each morningand evening. 3. Shark Cartilage - 5 capsules (250 mg each) each morning and evening. 4. Heritage Dino Bites - (montmorillinite minerals) 1 tablet (300 mg) each morning and evening. 5. Vitamin C - 2 tablets (500 mg each) each morning and evening. 6. Beta Carotene (Vitamin A) - 1 capsule (25,000 IU) every two days. 7. Heritage Complete - 2 tablets each morning and evening. Each tablet consists of multivitamins and minerals:: Vitamin A 1,666 IU Vitamin C 100 mg Vitamin D 66 IU Vitamin E 33 IU Vitamin K 13 mcg Thiamin 2.5 mg Riboflavin 2.8 mg Niacin 17 mg Vitamin B6 3.3 mg Folic Acid 67 mcg Vitamin B12 10 mcg Biotin 50 mcg Pantothenic Acid 10 mg Calcium proteinate 17 mg Iodine 25 mcg Magnesium 17 mg Zinc 2.5 mg Selenium 12 mcg Copper proteinate 0.33 mg Manganese 1.7 mg Chromium 34 mcg Molybdenum 17 mcg Potassium 17 mg Garlic Cloves 83 mg Choline 34 mg Inositol 17 mg PABA 17 mg Boron 0.5 mg Octosanol 0.5 mg Silicon 0.17 mg Vanadium 17 mcg Blend: Chlorella, Korean Ginseng, Lemon bioflavenoids, Papain, Rose Hips, Rutin, Coenzyme Q 10. 8. Heritage Osteoguard - 1 tablet each morning and evening. Each tablet contains: Vitamin D 10 IU Hydroxyadpatite and citrate 250 mg Magnesium (as citrate) 100 mg 9. Heritage Platinum - 2 capsules each morning and evening. Each capsule contains: Pine Bark Extract 10 mg Grape Seed Extract 40 mg Blend of citrus bioflavenoids, Rutin, Quercetin 10. Heritage Cat's Claw 1 1 capsule (600 mg) each morning andevening 11. Heritage Gold - 1 capsule each morning and evening. Each capsule contains Pancreatin, Lactase, Lipase, Amylase, Catalase, Chrymotrypsin, Trypsin, Cellulase, Zinc Gluconate. 12. Vitamin E - 1 softgel (400 IU) each morning and evening. 13. Essiac Tea - Drink 2 ounces oftea 3 times daily at least 20minutes prior to eating. 14. Hydrazine Sulfate - 60 mg tablets. A. One tablet daily for first three days. B. Two tablets daily for days 4, 5, and 6.C. Three tablets daily for the following 46 days. D. No tablets for 7 days. -
TABLE 2 Products and Dosage 1. Flax Oil - 2 capsules (1,000 mg each) each morning and evening. 2. Heritage Omega-3 Oil - 2 capsules (1,000 mg each) each morning and evening. 3. Shark Cartilage - 10 capsules (250 mg each) each morning and evening. 4. Heritage Dino Bites - (montmorillinite minerals) 1 tablet (300 mg) each morning and evening. 5. Vitamin C - 2 tablets (500 mg each) each morning and evening. 6. Beta Carotene (Vitamin A) - 1 capsule (10,000 IU) every morning. 7. Heritage Complete - 3 tablets each morning and evening. Each tablet consists of multivitamins and minerals:: Vitamin A 1,666 IU Vitamin C 100 mg Vitamin D 66 IU Vitamin E 33 IU Vitamin K 13 mcg Thiamin 2.5 mg Riboflavin 2.8 mg Niacin 17 mg Vitamin B6 3.3 mg Folic Acid 67 mcg Vitamin B12 10 mcg Biotin 50 mcg Pantothenic Acid 10 mg Calcium proteinate 17 mg Iodine 25 mcg Magnesium 17 mg Zinc 2.5 mg Selenium 12 mcg Copper proteinate 0.33 mg Manganese 1.7 mg Chromium 34 mcg Molybdenum 17 mcg Potassium 17 mg Garlic Cloves 83 mg Choline 34 mg Inositol 17 mg PABA 17 mg Boron 0.5 mg Octosanol 0.5 mg Silicon 0.17 mg Vanadium 17 mcg Blend: Chlorella, Korean Ginseng, Lemon bioflavenoids, Papain, Rose Hips, Rutin, Coenzyme Q 10. 8. Heritage Osteoguard - 1 tablet each morning and evening. Each tablet contains: Vitamin D 10 IU Hydroxyadpatite and citrate 250 mg Magnesium (as citrate) 100 mg 9. Heritage Platinum - 2 capsules each morning and evening. Each capsule contains: Pine Bark Extract 10 mg Grape Seed Extract 40 mg Blend of citrus bioflavenoids, Rutin, Quercetin 10. Heritage Cat's Claw - 1 capsule (600 mg) each morning and evening 11. Heritage Gold - 1 capsule each morning and evening. Each capsule contains Pancreatin, Lactase, Lipase, Amylase, Catalase, Chrymotrypsin, Trypsin, Cellulase, Zinc Gluconate. 12. Vitamin E - 1 softgel (400 IU) each morning and evening. 13. Essiac Tea - Drink 2 ounces oftea 3 times daily at least 20 minutesprior to eating. - In another embodiment, the user may also be encouraged to modify their diet in two main ways. First, to greatly reduce fat content to less than 25% of total daily caloric intake, especially of saturated fats. Second, to add daily portions of cruciferous vegetables at every meal possible. In combination with other aspects of the invention, the multiple synergies and backups may provide more effective control than any one treatment or therapy.
- As shown in
FIG. 1 the invention may be presented to a user in a unit dose design. The appropriate dose of each ingredient may even be packaged for sequential use, such as once each morning and evening by the user. This design may increase the accuracy and timing of the dosing by the patient, and may increase the efficacy. Given the need to maintain a consistent level of each ingredient in the patient, one goal of this feature of the invention may be to make a complex administration system easier for the patient to take the proper dosage at the correct times. - In one preferred embodiment, the proper dosage of each of the ingredients may be included as part of a package of ingredients (5) that comprises daily portions of a multi-day supply (such as a one week or seven day supply, e.g.) usable in a health enhancement program for use by the patient at the preferred times, e.g., once each morning and evening. However, other dosages and timings may be appropriate to give the intended result. In this regard, combinations using morning and evening administrations as well as three times per day, four times per day, and even once per day (as but a few examples) should be understood as encompassed by this disclosure as each may be appropriate in a given context. In at least one embodiment, the ingredients are relationally coordinated in that the type and/or dosage and/or timing is selected to cause a health enhancing effect. Based on the information gathered through the use of the data collection system, dosages and timings of each ingredient may even be altered, increased or decreased to maximize the effectiveness. A rapid feedback process may even be implemented to optimize effectiveness for each user.
- As a way to assure or perhaps enhance efficacy, and perhaps also as a way to encourage usage and even track the effectiveness of the invention, a data collection system may be implemented. In one embodiment, certain personal, usage, and/or medical records of the patient/customer may be collected. One goal of this system may be to insure that information is gathered which may be necessary to allow the effectiveness of the invention to be demonstrated, and which may be useful to consider adjustments made to the ingredients, timing, dosages and packaging system for maximum effectiveness, and which may be useful for marketing purposes. Additionally, this system may serve to encourage the customer/patient to be under the care of a medical professional which may not only assure optimal care, but it may also enhance the perceptions by the patient and thereby enhance the system's effectiveness.
- In a preferred embodiment, the data collection system may be designed to require that each patient/customer of a kit produce certain medical records at the time of purchase. These records may include diagnosis, prognosis, list of current medicines, treatment and medical history and other appropriate tests such as blood tests etc. Periodically, the patient/customer may also be required to update these medical records, such as on a monthly, weekly, bi-weekly, or even bimonthly basis, but at least at the time of each subsequent sale, in order to track the progress of their disease and perhaps even determine the propriety of any additional purchases.
- It may be useful to note that the invention and its formulation appear to have produced what may be considered by some to be spectacular results. Although these results may be considered as only representing a limited test basis, they are significant to those having used the system (including an inventor hereof relative to an advanced case of one of the most deadly forms of cancer, multiple myeloma or bone cancer). Through the use of data collected under one embodiment, further analysis of the results may also be accomplished.
- As mentioned earlier, the present invention includes a variety of aspects, which may be combined in different ways. The following descriptions are provided to list elements and describe some of the embodiments of the present invention. These elements are listed with initial embodiments, however it should be understood that they may be combined in any manner and in any number to create additional embodiments. The variously described examples and preferred embodiments should not be construed to limit the present invention to only the explicitly described systems, techniques, and applications. Further, this description should further be understood to support and encompass descriptions and claim of all the various embodiments, systems, techniques, methods, devices, and applications with any number of the disclosed elements, with each element alone, and also with any and all various permutations and combinations of all elements in this or any subsequent application.
- As can be easily understood from the foregoing, the basic concepts of the present invention may be embodied in a variety of ways. The invention may be considered as involving a combination of ingredients, formulations of the ingredients, timing and dosages of ingredients, a unit dose system, a health enhancement system that establishes a health enhancement program, a packaging system and the like as well as all combinations and permutations of these to improve the efficacy of treatments. It may also include a data collection system to accomplish the desired result of slowing or stopping the growth of cancer cells or the disease in humans and other purposes. While some ingredients, formulations, dosing, methods of packaging and a system of data collection are disclosed, it should be understood that these not only accomplish certain results but also can be varied in a number of ways. Importantly, as to all of the foregoing each and all of these facets should be understood to be encompassed by this disclosure.
- It involves both health enhancement techniques as well as devices to accomplish the appropriate and desired enhancement or improvement of health. In this application, the health enhancement techniques are disclosed as part of the results shown to be achieved by the various devices described and as steps which are inherent to utilization. They are simply the natural result of utilizing the devices as intended and described. In addition, while some devices are disclosed, it should be understood that these not only accomplish certain methods but also can be varied in a number of ways. Importantly, as to all of the foregoing, all of these facets should be understood to be encompassed by this disclosure.
- The discussion included in this non-provisional application is intended to serve as a basic description. The reader should be aware that the specific discussion may not explicitly describe all embodiments possible; many alternatives are implicit. It also may not fully explain the generic nature of the invention and may not explicitly show how each feature or element can actually be representative of a broader function or of a great variety of alternative or equivalent elements. Again, these are implicitly included in this disclosure. Where the invention is described in device-oriented terminology, each element of the device implicitly performs a function. Apparatus claim may not only be included for the device described, but also method or process claim may be included to address the functions the invention and each element performs. Neither the description nor the terminology is intended to limit the scope of the claim included in this patent application.
- It should also be understood that a variety of changes may be made without departing from the essence of the invention. Such changes are also implicitly included in the description. They still fall within the scope of this invention. A broad disclosure encompassing both the explicit embodiment(s) shown, the great variety of implicit alternative embodiments, and the broad methods and/or processes and/or systems and the like are encompassed by this disclosure, in addition to certain narrower embodiments. With this understanding, the reader should be aware that this disclosure is to be understood to support the claim in this patent application. It should be understood that the applicant may later seek examination of, e.g., even broader claim deemed within the applicant's right.
- Further, each of the various elements of the invention and claim may also be achieved in a variety of manners. This disclosure should be understood to encompass each such variation, be it a variation of an embodiment of any apparatus embodiment, a method or process embodiment, or even merely a variation of any element of these. Particularly, it should be understood that as the disclosure relates to elements of the invention, the words for each element may be expressed by equivalent apparatus terms or method terms—even if only the function or result is the same. Such equivalent, broader, or even more generic terms should be considered to be encompassed in the description of each element or action. Such terms can be substituted where desired to make explicit the implicitly broad coverage to which this invention is entitled. As but one example, it should be understood that all actions may be expressed as a means for taking that action or as an element which causes that action. Similarly, each physical element disclosed should be understood to encompass a disclosure of the action which that physical element facilitates. Regarding this last aspect, as but one example, the disclosure of a “package” should be understood to encompass disclosure of the act of “packaging”—whether explicitly discussed or not—and, conversely, were there effectively disclosure of the act of “packaging”, such a disclosure should be understood to encompass disclosure of a “package” and even a “means for packaging”. Such changes and alternative terms are to be understood to be explicitly included in the description.
- Any acts of law, statutes, regulations, or rules mentioned in this application for patent; or patents, publications, or other references mentioned in this application for patent are hereby incorporated by reference. In addition, as to each term used it should be understood that unless its utilization in this application is inconsistent with such interpretation, common dictionary definitions should be understood as incorporated for each term and all definitions, alternative terms, and synonyms such as contained in the Random House Webster's Unabridged Dictionary, second edition are hereby incorporated by reference. Finally, all references listed in the list of References To Be Incorporated By Reference In Accordance With The Provisional Patent Application or other information statement filed with the application are hereby appended and hereby incorporated by reference, however, as to each of the above, to the extent that such information or statements incorporated by reference might be considered inconsistent with the patenting of this/these invention(s) such statements are expressly not to be considered as made by the applicant(s).
- Thus, the applicant(s) should be understood to have support to claim and make a statement of invention to at least: i) each of the health enhancement systems as herein disclosed and described, ii) the related methods disclosed and described, iii) similar, equivalent, and even implicit variations of each of these systems and methods, iv) those alternative designs which accomplish each of the functions shown as are disclosed and described, v) those alternative designs and methods which accomplish each of the functions shown as are implicit to accomplish that which is disclosed and described, vi) each feature, component, and step shown as separate and independent inventions, vii) the applications enhanced by the various systems or components disclosed, viii) the resulting products produced by such systems or components, ix) each system, method, and element shown or described as now applied to any specific field or devices mentioned, x) methods and apparatuses substantially as described hereinbefore and with reference to any of the accompanying examples, xi) the various combinations and permutations of each of the elements disclosed, and xii) each potentially dependent claim or concept as a dependency on each and every one of the independent claim or concepts presented.
- With regard to claim whether now or later presented for examination, it should be understood that for practical reasons and so as to avoid great expansion of the examination burden, the applicant may at any time present only initial claim or perhaps only initial claim with only initial dependencies. Support should be understood to exist to the degree required under new matter laws—including but not limited to European Patent Convention Article 123(2) and United States patent Law 35 USC 132 or other such laws—to permit the addition of any of the various dependencies or other elements presented under one independent claim or concept as dependencies or elements under any other independent claim or concept. In drafting any claim at any time whether in this application or in any subsequent application, it should also be understood that the applicant has intended to capture as full and broad a scope of coverage as legally available. To the extent that insubstantial substitutes are made, to the extent that the applicant did not in fact draft any claim so as to literally encompass any particular embodiment, and to the extent otherwise applicable, the applicant should not be understood to have in any way intended to or actually relinquished such coverage as the applicant simply may not have been able to anticipate all eventualities; one skilled in the art, should not be reasonably expected to have drafted a claim that would have literally encompassed such alternative embodiments.
- Further, if or when used, the use of the transitional phrase “comprising” is used to maintain the “open-end” claim herein, according to traditional claim interpretation. Thus, unless the context requires otherwise, it should be understood that the term “comprise” or variations such as “comprises” or “comprising”, are intended to imply the inclusion of a stated element or step or group of elements or steps but not the exclusion of any other element or step or group of elements or steps. Such terms should be interpreted in their most expansive form so as to afford the applicant the broadest coverage legally permissible.
- Finally, any claim set forth at any time are hereby incorporated by reference as part of this description of the invention, and the applicant expressly reserves the right to use all of or a portion of such incorporated content of such claim as additional description to support any of or all of the claim or any element or component thereof, and the applicant further expressly reserves the right to move any portion of or all of the incorporated content of such claim or any element or component thereof from the description into the claim or vice-versa as necessary to define the matter for which protection is sought by this application or by any subsequent continuation, division, or continuation-in-part application thereof, or to obtain any benefit of, reduction in fees pursuant to, or to comply with the patent laws, rules, or regulations of any country or treaty, and such content incorporated by reference shall survive during the entire pendency of this application including any subsequent continuation, division, or continuation-in-part application thereof or any reissue or extension thereon.
Claims (7)
1-30. (canceled)
31. A package of ingredients usable in a health enhancement program, wherein said package of ingredients comprises:
daily portions of a seven day supply of each of said ingredients, said ingredients comprising:
flax oil;
omega-3 oil;
shark cartilage;
montmorillinite minerals;
vitamin C;
Heritage Complete™;
Heritage Osteoguard™;
Heritage Platinum™;
Cat's Claw;
Heritage Gold™; and
vitamin E; and
portions of a seven day supply of beta carotene,
wherein said ingredients are relationally coordinated to enhance health when ingested according to said health enhancement program.
32. A package of ingredients usable in a health enhancement program as described in claim 31 wherein said package of ingredients further comprises hydrazine sulfate.
33. A package of ingredients usable in a health enhancement program as described in claim 32 wherein:
said daily portions of a seven day supply of flax oil comprise daily portions each in the amount of 4,000 mgs.;
said daily portions of a seven day supply of omega-3 oil comprise daily portions each in the amount of 4,000 mgs.;
said daily portions of a seven day supply of shark cartilage comprise daily portions each in the amount of 1250 mgs.;
said daily portions of a seven day supply of montmorillinite minerals comprise daily portions each in the amount of 600 mgs.;
said daily portions of a seven day supply of vitamin C comprise daily portions each in the amount of 2000 mgs.;
said daily portions of a seven day supply of Heritage Complete™ comprise daily portions each in the amount of four tablets;
said daily portions of a seven day supply of Heritage Osteoguard™ comprise daily portions each in the amount of two tablets;
said daily portions of a seven day supply of Heritage Platinum™ comprise daily portions each in the amount of four capsules;
said daily portions of a seven day supply of Cat's Claw comprise daily portions each in the amount of 1200 mgs.;
said daily portions of a seven day supply of Heritage Gold™ comprise daily portions each in the amount of two capsules;
said daily portions of a seven day supply of Vitamin E comprise daily portions each in the amount of 800 IU.;
said portions of a seven day supply of beta carotene comprise two-day portions each in the amount of 25,000 IU;
wherein said daily portions of a seven day supply of hydrazine sulfate comprise an amount appropriate as specified by the following hydrazine schedule: 60 mg. hydrazine sulfate daily for the first three days of administration of said health enhancement program; 120 mgs. hydrazine sulfate daily for days 4, 5, and 6 of administration of said health enhancement program; 180 mgs. hydrazine sulfate daily for days 7 through 52 of administration of said health enhancement program; and no hydrazine sulfate for days 53 through 60 of administration of said health enhancement program.
34. A package of ingredients usable in a health enhancement program as described in claim 31 wherein:
said daily portions of a seven day supply of flax oil comprise daily portions each in the amount of 4,000 mgs.;
said daily portions of a seven day supply of omega-3 oil comprise daily portions each in the amount of 4,000 mgs.;
said daily portions of a seven day supply of shark cartilage comprise daily portions each in the amount of 5,000 mgs.;
said daily portions of a seven day supply of montmorillinite minerals comprise daily portions each in the amount of 600 mgs.;
said daily portions of a seven day supply of vitamin C comprise daily portions each in the amount of 2000 mgs.;
said daily portions of a seven day supply of Heritage Complete™ comprise daily portions each in the amount of six tablets;
said daily portions of a seven day supply of Heritage Osteoguard™ comprise daily portions each in the amount of two tablets;
said daily portions of a seven day supply of Heritage Platinum™ comprise daily portions each in the amount of four capsules;
said daily portions of a seven day supply of Cat's Claw comprise daily portions each in the amount of 1200 mgs.;
said daily portions of a seven day supply of Heritage Gold™ comprise daily portions each in the amount of two capsules;
said daily portions of a seven day supply of Vitamin E comprise daily portions each in the amount of 800 IU.;
said portions of a seven day supply of beta carotene comprise daily portions each in the amount of 10,000 IU.
35. A package of ingredients usable in a health enhancement program as described in claim 31 , 32 , 33 or 34 wherein said package of ingredients further comprises essiac tea.
36. A package of ingredients usable in a health enhancement program as described in claim 31 , 33 or 34 wherein said Omega-3 Oil comprises Heritage Omega-3 Oil™, wherein said montmorillinite minerals comprises Dino Bites™, wherein said Cat's Claw comprises Heritage Cat's Claw™.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/861,132 US20090004168A1 (en) | 2002-07-01 | 2007-09-25 | Health Enhancement System |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39371702P | 2002-07-01 | 2002-07-01 | |
US10/612,321 US7273607B2 (en) | 2002-07-01 | 2003-07-01 | Health enhancement method |
US11/861,132 US20090004168A1 (en) | 2002-07-01 | 2007-09-25 | Health Enhancement System |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/612,321 Division US7273607B2 (en) | 2002-07-01 | 2003-07-01 | Health enhancement method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090004168A1 true US20090004168A1 (en) | 2009-01-01 |
Family
ID=31997450
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/612,321 Expired - Fee Related US7273607B2 (en) | 2002-07-01 | 2003-07-01 | Health enhancement method |
US11/861,132 Abandoned US20090004168A1 (en) | 2002-07-01 | 2007-09-25 | Health Enhancement System |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/612,321 Expired - Fee Related US7273607B2 (en) | 2002-07-01 | 2003-07-01 | Health enhancement method |
Country Status (1)
Country | Link |
---|---|
US (2) | US7273607B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160235284A1 (en) * | 2013-09-30 | 2016-08-18 | Nagase Medicals Co., Ltd. | Endoscope lens cleaner |
US11302434B2 (en) * | 2019-09-03 | 2022-04-12 | International Business Machines Corporation | Nutrition-based management of health conditions using machine learning |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7611732B2 (en) * | 2004-07-26 | 2009-11-03 | Michael Bentley | Nutritional supplement for osteoarthritis |
RU2377007C1 (en) * | 2008-06-23 | 2009-12-27 | Открытое Акционерное Общество "Инвестиционная Финансовая Группа "Гленик-М" | Agent for treatment and prevention of oncologic diseases and method of application said agent (versions) |
US8916612B2 (en) * | 2008-09-11 | 2014-12-23 | Gad Gilad | Agmatine containing dietary supplements, nutraceuticals, and foods |
WO2010030470A1 (en) * | 2008-09-11 | 2010-03-18 | Gilad Gad M | Agmatine containing dietary supplements, nutraceuticals, and foods |
US20100247670A1 (en) * | 2009-03-26 | 2010-09-30 | Dmitriy Shoutov | Red Grape Dry Composition and Health Tea |
KR20170020859A (en) * | 2014-06-12 | 2017-02-24 | 포 엘엘씨 | Sweet taste receptor antagonist compositions |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950164A (en) * | 1989-11-17 | 1990-08-21 | Kraft General Foods, Inc. | Diet planning and control system and method |
US5044958A (en) * | 1989-12-26 | 1991-09-03 | Robertson Herbert R | Method for planning and controlling diet |
US5536523A (en) * | 1991-03-22 | 1996-07-16 | Ogam Limited | Spread |
US5547947A (en) * | 1993-03-11 | 1996-08-20 | Hoffmann-La Roche Inc. | Methods of treatment |
US5807586A (en) * | 1996-07-30 | 1998-09-15 | Energetics, Inc. | Method of dietary supplementation |
US5833072A (en) * | 1997-07-10 | 1998-11-10 | Ortho Pharmaceutical Corporation | Dosage regimen container |
US6040333A (en) * | 1996-07-30 | 2000-03-21 | Energetics, Inc. | Dietary supplements |
US6039978A (en) * | 1995-06-06 | 2000-03-21 | Campbell Soup Company | Dietary food enhancement agent |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
US6090414A (en) * | 1970-05-20 | 2000-07-18 | Life Science Labs, Inc. | Method and composition to reduce cancer incidence |
US6102706A (en) * | 1995-06-06 | 2000-08-15 | Campbell Soup Company | Compliance support package for increasing health management system compliance |
US6133317A (en) * | 1995-11-15 | 2000-10-17 | Hart; Francis J. | Oxalic acid or oxalate composition and method of treatment |
US6242435B1 (en) * | 1998-07-16 | 2001-06-05 | Gentrix Llc | Compositions and methods of treating abnormal cell proliferation |
US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
US6949264B1 (en) * | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
US7005513B1 (en) * | 1999-04-02 | 2006-02-28 | Netech, Inc. | Functionalized glycosaminoglycan polymer and medical instruments and drugs by using the same |
USRE40510E1 (en) * | 1996-05-07 | 2008-09-23 | Medco Health Solutions, Inc. | Automatic prescription filling, sorting and packaging system |
-
2003
- 2003-07-01 US US10/612,321 patent/US7273607B2/en not_active Expired - Fee Related
-
2007
- 2007-09-25 US US11/861,132 patent/US20090004168A1/en not_active Abandoned
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6090414A (en) * | 1970-05-20 | 2000-07-18 | Life Science Labs, Inc. | Method and composition to reduce cancer incidence |
US4950164A (en) * | 1989-11-17 | 1990-08-21 | Kraft General Foods, Inc. | Diet planning and control system and method |
US5044958A (en) * | 1989-12-26 | 1991-09-03 | Robertson Herbert R | Method for planning and controlling diet |
US5536523A (en) * | 1991-03-22 | 1996-07-16 | Ogam Limited | Spread |
US5547947A (en) * | 1993-03-11 | 1996-08-20 | Hoffmann-La Roche Inc. | Methods of treatment |
US5856317A (en) * | 1993-03-11 | 1999-01-05 | Hoffmann-La Roche Inc. | Methods of treatment |
US5891866A (en) * | 1993-03-11 | 1999-04-06 | Hoffman-La Roche Inc. | Methods of treatment |
US6102706A (en) * | 1995-06-06 | 2000-08-15 | Campbell Soup Company | Compliance support package for increasing health management system compliance |
US6039978A (en) * | 1995-06-06 | 2000-03-21 | Campbell Soup Company | Dietary food enhancement agent |
US6133317A (en) * | 1995-11-15 | 2000-10-17 | Hart; Francis J. | Oxalic acid or oxalate composition and method of treatment |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
USRE40510E1 (en) * | 1996-05-07 | 2008-09-23 | Medco Health Solutions, Inc. | Automatic prescription filling, sorting and packaging system |
US5807586A (en) * | 1996-07-30 | 1998-09-15 | Energetics, Inc. | Method of dietary supplementation |
US6040333A (en) * | 1996-07-30 | 2000-03-21 | Energetics, Inc. | Dietary supplements |
US6949264B1 (en) * | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
US5833072A (en) * | 1997-07-10 | 1998-11-10 | Ortho Pharmaceutical Corporation | Dosage regimen container |
US6242435B1 (en) * | 1998-07-16 | 2001-06-05 | Gentrix Llc | Compositions and methods of treating abnormal cell proliferation |
US7005513B1 (en) * | 1999-04-02 | 2006-02-28 | Netech, Inc. | Functionalized glycosaminoglycan polymer and medical instruments and drugs by using the same |
US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160235284A1 (en) * | 2013-09-30 | 2016-08-18 | Nagase Medicals Co., Ltd. | Endoscope lens cleaner |
US11302434B2 (en) * | 2019-09-03 | 2022-04-12 | International Business Machines Corporation | Nutrition-based management of health conditions using machine learning |
Also Published As
Publication number | Publication date |
---|---|
US20040052871A1 (en) | 2004-03-18 |
US7273607B2 (en) | 2007-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090004168A1 (en) | Health Enhancement System | |
CN102056499A (en) | Composition for regulating lipid metabolism | |
CN102160664A (en) | Nutritious drink for children | |
US20030044512A1 (en) | Liver function improvement formulation | |
US20060269623A1 (en) | Herbal composition and method of use for promoting erections and treating erectile dysfunction in men | |
CN102526346A (en) | Health-care pharmaceutical formulation with immunity-enhancing and senility-delaying functions | |
KR20110117685A (en) | A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement | |
KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
CN112273490A (en) | Hawthorn and ginger tea potion | |
KR20030013221A (en) | Onion powder, onion pickles, onion soy sauce, onion red pepper paste, onion miso | |
CN1948451A (en) | Health care wine and its preparation method | |
KR20140106058A (en) | Composition for enhancing immunological activity comprising soluble salmon milt extract and vegetable lactic acid bacteria | |
CN109805235B (en) | Wheat-flavor composite polypeptide solid beverage for assisting in reducing hypertension, hyperglycemia and hyperlipidemia, and preparation method and application thereof | |
CN104473173B (en) | Prevent health food of person in middle and old age's angiocardiopathy and preparation method thereof | |
Dégraff | The Complete Guide to Growing and Using Wheatgrass: Everything You Need to Know Explained Simply | |
Brewer | The Essential Guide to Vitamins, Minerals and Herbal Supplements | |
US20070264314A1 (en) | Process and formula for treating irritable bowel syndrome | |
CN108883145A (en) | A kind of medicament for oral administration applying combined treatment AIDS, tumour outside | |
CN109954052A (en) | A kind of composition with antioxidant activity | |
CN101966263A (en) | SOD (Super Oxide Dlsmutase) oxidation-resistant health product | |
Mindell | Earl Mindell's Supplement Bible: A Comprehensive Guide to Hundreds of NEW Natural Products that Will Help You Live Longer, Look Better, Stay Heathier, Improve Strength and Vitality, and Much More! | |
Tewfik et al. | Nutraceuticals, functional foods and botanical dietary supplements; promote wellbeing and underpin public health | |
KR20170014237A (en) | Fermented black garlic and black onion comprising jellystick and Preparation Method Thereof | |
RU2176893C2 (en) | Biologically active food supplement "dnaavit" | |
Brewer | The Daily Telegraph: Encyclopedia of Vitamins, Minerals& Herbal Supplements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |